2 suspended. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Suspended 2 |
Follow Peritoneal Diseases: new trials by email Literature Review of Peritoneal Diseases trials Research Report on Peritoneal Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Malignant Peritoneal Mesothelioma (MESOTIP) PIPAC, Cisplatin, Pemetrexed - Peritoneal Mesothelioma, Peritoneal Carcinomatosis | Phase 2 | Suspended | Institut du Cancer de Montpellier - Val d'Aurelle | 66 | 2020-09-10 | 2026-02-09 |
| Clinical Trial at Neoadjuvant Peritoneal and Systemic Chemotherapy Plus HIPEC in Gastric Carcinomatosis Intraperitoneal and systemic chemotherapy plus maximum cytoreduction plus HIPEC - Peritoneal Carcinomatosis, Gastric Cancer | Phase 2 | Suspended | Hospital General Universitario Gregorio Marañon | 50 | 2011-01-01 | 2016-11-21 |
Peritoneal Neoplasms (2) · Carcinoma (1) · Neoplasms (1) · Stomach Neoplasms (1)
Abdominal Neoplasms (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Neoplasms by Site (2) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1) · Stomach Diseases (1)
Cisplatin (1) · Doxorubicin (1) · Hyperthermic Intraperitoneal Chemotherapy (1) · Infusions, Parenteral (1) · Pemetrexed (1)
Hospital General Universitario Gregorio Marañon (1) · Institut du Cancer de Montpellier - Val d'Aurelle (1)
France (1) · Spain (1)
2009 (1)